Computational Validation of the Importance of Absolute Stereochemistry in Virtual Screening
暂无分享,去创建一个
Kenyon G. Daniel | Shen-Shu Sung | Wayne C. Guida | Wesley H. Brooks | W. Guida | K. Daniel | S. Sung | W. Brooks
[1] W. Sellers,et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2 , 1995, Nature.
[2] Xueliang Fang,et al. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. , 2006, Journal of medicinal chemistry.
[3] FDA's policy statement for the development of new stereoisomeric drugs. , 1992, Chirality.
[4] J. An,et al. Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.
[5] E. J. Ariëns. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology , 2004, European Journal of Clinical Pharmacology.
[6] Suto,et al. Designing chiral libraries for drug discovery. , 2000, Drug discovery today.
[7] Philip E. Bourne,et al. The Protein Data Bank (PDB) | NIST , 2002 .
[8] Gerhard Klebe,et al. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..
[9] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[10] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[11] J. O'grady,et al. Drug chirality: a consideration of the significance of the stereochemistry of antimicrobial agents. , 1996, The Journal of antimicrobial chemotherapy.
[12] Ann Thayer,et al. Centering on chirality , 2007 .
[13] L. Vassilev,et al. Targeting the p53–MDM2 interaction to treat cancer , 2004, British Journal of Cancer.
[14] J. Caldwell. The importance of stereochemistry in drug action and disposition. , 1992, Journal of clinical pharmacology.
[15] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.